Hyperphosphatemia: Clinical Trials

2 trials for Hyperphosphatemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2
Phase 22Unknown 2

Follow Hyperphosphatemia: new trials by email Literature Review of Hyperphosphatemia trials Research Report on Hyperphosphatemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder
Lanthanum Polystyrene Sulphonate Powder, Lanthanum Carbonate 500 MG, Placebo - Hyperphosphatemia
Phase 1 / Phase 2UnknownGrand Life Science (Liaoning) Co., Ltd.482020-10-212021-07-28
A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis
VS-505 - End Stage Renal Disease, Hyperphosphatemia
Phase 1 / Phase 2UnknownKDL Inc.302015-06-012016-02-08

Narrower conditions

Kidney Failure, Chronic (1)

Broader conditions

Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Phosphorus Metabolism Disorders (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

lanthanum carbonate (1)

Sponsors

Grand Life Science (Liaoning) Co., Ltd. (1)  ·  KDL Inc. (1)

Countries

Australia (1)  ·  China (1)

Top investigators

Johan Rosman, MD, Ph.D (1)  ·  Yanhua Ding, Ph.D (1)